Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1787 |
Levobupivacaine
|
Sodium Channel | Membrane transporter/Ion channel |
Levobupivacaine 是一种氨基酰胺类局麻药,属于n-alkylsubstituted pipecoloxylidide 家族。它是bupivacaine 的 S-对映异构体。 | |||
T6566 |
Levobupivacaine hydrochloride
Levobupivacaine HCl,(S)-(-)-Bupivacaine HCl,盐酸左布比卡因,(S)-(-)-Bupivacaine monohydrochloride |
Sodium Channel | Membrane transporter/Ion channel |
Levobupivacaine hydrochloride ((S)-(-)-Bupivacaine monohydrochloride) 是有效的钠通道阻滞剂。 | |||
T3575 |
Acecainide hydrochloride
ASL 601,NAPA |
Others | Others |
Acecainide hydrochloride (NAPA) 是 PROCAINAMIDE 的主要代谢物。其抗心律失常作用可能导致肾衰竭时的心脏毒性。 | |||
T77550 |
O-Desmethyl Quinidine
|
Others | Others |
O-Desmethyl Quinidine 是一种新型的奎尼丁类似物,具有显着的抗心律失常活性和较低的急性毒性,可能有助于治疗心律失常。 | |||
T21327 |
Uridine triacetate
RG 2133 triacetate,PN-401,Tri-O-acetyluridine,PN401,RG 2133,RG-2133,PN 401,RG2133,RG2133 triacetate |
Others | Others |
Uridine triacetate (RG 2133 triacetate) 是一种具有口服活性的 Uridine 前药。Uridine triacetate 能在肠道内迅速被吸收,在循环中迅速脱乙酰,生成游离尿苷。Uridine triacetate 可用于研究 5-氟尿嘧啶 (5-FU) 和卡培他滨的毒性,或早发性心脏或中枢神经系统 (CNS) 毒性。 | |||
T12794 |
(S)-Carvedilol
(S)-BM 14190,(S)-卡维地洛 |
Others | Others |
(S)-Carvedilol is a non-selective β/α-1 blocker.It exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX). | |||
T12615 |
(R)-Carvedilol
(R)-BM 14190,(R)-卡维地洛 |
Others | Others |
(R)-Carvedilol is a non-selective blocker of β/α-1. (R)-Carvedilol exerts protection against the vascular or cardiac toxicity of Doxorubicin (DOX). | |||
T79288 |
Antitubercular agent-38
|
||
Antitubercula agent-38,一种具有效抗结核活性的口服苯并噻嗪酮(BTZ)衍生物,其特点为低心脏毒性和低细胞毒性。 | |||
T78524 | Polystyrene | Others | Others |
聚苯乙烯微塑料(PS-MPs)是一种潜在的有毒危害物质,对斑马鱼心脏造成损害,同时能诱导小鼠雄性生殖毒性。 | |||
T82415 |
Fasciculin-I
FAS-I |
||
Fasciculin-I 是从曼巴蛇的毒液中分离出的化合物。该物质通过抑制乙酰胆碱酯酶(AChE)来发挥其毒性,同时阻碍烟碱乙酰胆碱受体与α-神经毒素以及心脏毒素与细胞膜的相互作用。 | |||
T68336 |
Amrubicin HCl
|
||
Amrubicin, also known as SM-5887, is an anthracycline used in the treatment of lung cancer. Amrubicin intercalates into DNA and inhibits the activity of topoisomerase II, resulting in inhibition of DNA replication, and RNA and protein synthesis, followed by cell growth inhibition and cell death. This agent has demonstrated a higher level of anti-tumor activity than conventional anthracycline drugs without exhibiting any indication of the cumulative cardiac toxicity common to this class of compo... | |||
T62004 |
(Rac)-Nebivolol
|
||
(Rac)-Nebivolol ((Rac)-R 065824) 是 Nebivolol 的外消旋异构体。Nebivolol 是一种选择性的β1 肾上腺素能受体拮抗剂(IC50= 0.8 nM)。Nebivolol 显示血管舒张活性。在乙醇引起心脏毒性的早期阶段,Nebivolol 能预防 Nox2/NADPH 氧化酶上调和脂质过氧化。 | |||
T60713 | TK-129 | ||
TK-129 是具有口服活性的 KDM5B 的有效抑制剂,IC50值为44 nM,并且具有低毒性。TK-129 发挥心脏保护作用,通过抑制 KDM5B 和阻断 KDM5B 相关的 Wnt 通路。TK-129 可用于研究心血管疾病,它能在体内减少异丙肾上腺素诱导的心肌重塑和纤维化,并且在体外减少 Ang II 诱导的心脏成纤维细胞活化。 | |||
T83768 |
Zofenoprilat
Zofenopril-SH,SQ 26,333 |
||
Zofenoprilat是一种血管紧张素转换酶(ACE; IC50 = 8 nM for the rabbit lung enzyme)的抑制剂,同时也是前体药zofenopril的活性代谢产物。它能够抑制分离的豚鼠小肠中由血管紧张素I或缓激肽诱导的收缩(EC50s = 3 and 1 nM, respectively)。在人类脐静脉内皮细胞(HUVECs)中,Zofenoprilat (10 nM)降低基础内皮素-1分泌和一氧化氮(NO)生成,并阻止TNF-α诱导的活性氧种(ROS)增加以及谷胱甘肽(GSH)水平降低。Zofenoprilat (10 µM)保护初级人类心脏微血管内皮细胞免受多柔比星诱导的细胞毒性。此外,Zofenoprilat (10 µM)还能增加HUVECs中的硫化氢(H2S)生成,以及细胞的黏着、迁移和增殖。在以400 µM浓度使用时,它可以减少Langendorff分离的大鼠心脏灌流缺血再灌注损伤模型中的舒张末压和乳酸脱氢酶(LDH)释放。 |